Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,917,765
+$572,353 QoQ
Shares Held
11,595
+7.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#1,668
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Intellectus Partners, LLC holds $12,763,770 across 10 Drug Manufacturers - General names. ABBV ranks #1 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
11,595 | $2,917,765 | |
| 2 | LLY |
ELI LILLY & Co
|
1,918 | $2,300,506 | |
| 3 | NVO |
Novo Nordisk A S
|
33,631 | $1,612,270 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,435 | $1,212,397 | |
| 5 | PFE |
Pfizer Inc
|
48,637 | $1,171,178 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
8,947 | $1,130,363 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,002 | $979,655 | |
| 8 | JNJ |
Johnson & Johnson
|
2,801 | $711,369 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,917,765 | 11,595 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,345,412 | 10,784 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $1,479,244 | 6,474 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,421,424 | 6,139 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,139,149 | 6,137 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,285,405 | 6,135 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $1,088,590 | 6,126 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,210,749 | 6,131 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,807,649 | 10,539 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $1,021,216 | 5,608 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,982,841 | 12,795 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,912,737 | 12,832 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $1,730,606 | 12,845 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $2,042,804 | 12,818 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,813,264 | 11,220 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,498,052 | 11,162 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,762,565 | 11,508 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,995,249 | 12,308 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,281,290 | 9,463 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,022,931 | 9,483 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,048,678 | 9,310 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $458,311 | 4,235 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,310,337 | 12,229 | Shares | Sole | 2021-02-18 | |
| 2020-09-30 | $1,128,947 | 12,889 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,460,231 | 14,873 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||